Clinical Trial Update: A Study to Test the Efficacy, Safety and Pharmacokinetics of Bimekizumab in Subjects With Moderate to Severe Hidradenitis Suppurativa. [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the efficacy, safety, and pharmacokinetics of bimekizumab in moderate to severe hidradenitis suppurativa has completed with po…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Hidradenitis Suppurativa

Drugs mentioned

• Bimekizumab (bimekizumab)

Snippet

Sponsor: UCB Biopharma SRL | Conditions: Hidradenitis Suppurativa | Phase 2 | Status: COMPLETED | Results posted: 2022-02-09